MCID: BTT001
MIFTS: 34

Bietti Crystalline Corneoretinal Dystrophy malady

Categories: Genetic diseases, Rare diseases, Eye diseases

Aliases & Classifications for Bietti Crystalline Corneoretinal Dystrophy

About this section

Aliases & Descriptions for Bietti Crystalline Corneoretinal Dystrophy:

Name: Bietti Crystalline Corneoretinal Dystrophy 51 11 23 47 24 25 53 69 26 12 13 67
Bietti Crystalline Dystrophy 23 24 25 53 69
Bietti Crystalline Retinopathy 23 24 25 53
Bcd 47 25 53 69
 
Bietti Tapetoretinal Degeneration with Marginal Corneal Dystrophy 47 25 69
Bietti's Crystalline Dystrophy 11
Crystalline Retinopathy 69

Characteristics:

Orphanet epidemiological data:

53
bietti crystalline corneoretinal dystrophy:
Inheritance: Autosomal recessive

HPO:

63
bietti crystalline corneoretinal dystrophy:
Inheritance: autosomal recessive inheritance

Classifications:

Orphanet: 53 
Rare eye diseases


External Ids:

OMIM51 210370
Disease Ontology11 DOID:0050664
Orphanet53 ORPHA41751
MESH via Orphanet39 C535440
ICD10 via Orphanet30 H15.5
MedGen36 C1859486

Summaries for Bietti Crystalline Corneoretinal Dystrophy

About this section
OMIM:51 Bietti crystalline corneoretinal dystrophy is an autosomal recessive retinal dystrophy characterized by numerous tiny... (210370) more...

MalaCards based summary: Bietti Crystalline Corneoretinal Dystrophy, also known as bietti crystalline dystrophy, is related to blepharocheilodontic syndrome and choroiditis, and has symptoms including severe myopia, progressive visual loss and chorioretinal atrophy. An important gene associated with Bietti Crystalline Corneoretinal Dystrophy is CYP4V2 (Cytochrome P450 Family 4 Subfamily V Member 2). Affiliated tissues include retina, eye and skin.

Genetics Home Reference:25 Bietti crystalline dystrophy is a disorder in which numerous small, yellow or white crystal-like deposits of fatty (lipid) compounds accumulate in the light-sensitive tissue that lines the back of the eye (the retina). The deposits damage the retina, resulting in progressive vision loss.

NIH Rare Diseases:47 Bietti crystalline corneoretinal dystrophy is an inherited eye disease. Symptoms include crystals in the cornea (the clear covering of the eye); yellow, shiny deposits on the retina; and progressive atrophy of the retina, choriocapillaries and choroid (the back layers of the eye). This tends to lead to progressive night blindness and loss of visual acuity. Bietti crystalline corneoretinal dystrophy is caused by mutations in the CYP4V2 gene and inherited in an autosomal recessive fashion.  Last updated: 7/5/2011

UniProtKB/Swiss-Prot:69 Bietti crystalline corneoretinal dystrophy: An autosomal recessive ocular disease characterized by retinal degeneration and marginal corneal dystrophy. Typical features include multiple glistening intraretinal crystals scattered over the fundus, a characteristic degeneration of the retina, and sclerosis of the choroidal vessels, ultimately resulting in progressive night blindness and constriction of the visual field. Most patients have similar crystals at the corneoscleral limbus. Patients develop decreased vision, nyctalopia, and paracentral scotomata between the 2nd and 4th decade of life. Later, they develop peripheral visual field loss and marked visual impairment, usually progressing to legal blindness by the 5th or 6th decade of life.

GeneReviews for NBK91457

Related Diseases for Bietti Crystalline Corneoretinal Dystrophy

About this section

Diseases related to Bietti Crystalline Corneoretinal Dystrophy via text searches within MalaCards or GeneCards Suite gene sharing:

idRelated DiseaseScoreTop Affiliating Genes
1blepharocheilodontic syndrome11.0
2choroiditis10.1
3retinoschisis10.0
4retinitis pigmentosa10.0
5retinitis10.0
6primary hyperoxaluria9.9
7eating disorder9.8
8dwarfism9.8
9microphthalmia, isolated, with coloboma 99.5CYP4V2, PPIG

Graphical network of diseases related to Bietti Crystalline Corneoretinal Dystrophy:



Diseases related to bietti crystalline corneoretinal dystrophy

Symptoms for Bietti Crystalline Corneoretinal Dystrophy

About this section

Symptoms by clinical synopsis from OMIM:

210370

Clinical features from OMIM:

210370

Human phenotypes related to Bietti Crystalline Corneoretinal Dystrophy:

 63 (show all 8)
id Description HPO Frequency HPO Source Accession
1 severe myopia63 rare (5%) HP:0011003
2 progressive visual loss63 HP:0000529
3 chorioretinal atrophy63 HP:0000533
4 retinal degeneration63 HP:0000546
5 constriction of peripheral visual field63 HP:0001133
6 abnormality of blood and blood-forming tissues63 HP:0001871
7 progressive night blindness63 HP:0007675
8 marginal corneal dystrophy63 HP:0007880

Drugs & Therapeutics for Bietti Crystalline Corneoretinal Dystrophy

About this section

Drugs for Bietti Crystalline Corneoretinal Dystrophy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 6)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Pyridoxineapproved, nutraceutical, vet_approved18665-23-61054
Synonyms:
(5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate
12001-78-4
2-Methyl-3-hydroxy-4,5-bis(hydroxymethyl)pyridine
2-Methyl-3-hydroxy-4,5-di(hydroxymethyl)pyridine
2-Methyl-3-hydroxy-4,5-dihydroxymethyl-pyridin
2-Methyl-3-hydroxy-4,5-dihydroxymethyl-pyridin [German]
2-Methyl-3-hydroxy-4,5-dihydroxymethylpyridine
2-Methyl-4,5-bis(hydroxymethyl)-3-hydroxypyridine
2-methyl-3-hydroxy-4,5-bis(hydroxy-methyl) pyridine
2-methyl-3-hydroxy-4,5-dihydroxymethylpyridine
2-methyl-4,5-dimethylol-pyridin-3-ol
2B3E07D2-E4CC-4CC5-B085-6070BA01F9F0
3,4-Pyridinedimethanol, 5-hydroxy-6-methyl-, hydrochloride
3-Hydroxy-2-Picoline-4,5-dimethanol
3-Hydroxy-4,5-dihydroxymethyl-2-methylpyridine hydrochloride
3-Hydroxy-4,5-dimethylol-.alpha.-picoline hydrochloride
3-Hydroxy-4,5-dimethylol-alpha-picoline
3-Hydroxy-4,5-dimethylol-alpha-picoline hydrochloride
3-hydroxy-4,5-bis(hydroxymethyl)-2-methylpyridine
4,5-Bis(hydroxymethyl)-2-methyl-3-pyridinol
4,5-Bis(hydroxymethyl)-2-methylpyridin-3-ol hydrochloride
4,5-bis(hydroxymethyl)-2-methyl-3-pyridinol hydrochloride
4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol
4,5-bis(hydroxymethyl)-2-methylpyridine-3-ol
4-Deoxypyridoxine 5'-phosphate
47862_SUPELCO
5-Hydroxy-6-methyl-3,4-pyridinedicarbinol hydrochloride
5-Hydroxy-6-methyl-3,4-pyridinedimethanol
5-Hydroxy-6-methyl-3,4-pyridinedimethanol hydrochloride
5-Hydroxy-6-methyl-3,4-pyridinedimethanol, hydrochloride
58-56-0
58-56-0 (HCL)
58-56-0 (hydrochloride)
65-23-6
65-23-6 (Parent)
8059-24-3
85078-23-5
AC-12024
AC-14512
AC-907/25014218
AC1L1AMH
AC1L1LMI
AC1L2XK2
AC1Q22HP
AC1Q2G66
AC1Q3F63
AI3-19016
AIDS-006784
AIDS006784
AR-1A6363
AR-1J1632
Adermin hydrochloride
Adermine
Adermine hydrochloride
Aderomine hydrochloride
Aderoxin
Aderoxine
Alestrol
BB_NC-0050
BIDD:PXR0180
BPBio1_000646
BSPBio_000586
Becilan
Beesix
Benadon
Bonasanit
C00314
C8H11NO3
CAS-58-56-0
CBDivE_015627
CCRIS 1903
CHEBI:16709
CHEBI:30961
CHEMBL1200756
CHEMBL1364
CID104817
CID1054
CID6019
CPD0-1221
Campoviton 6
Cernevit-12
D02179
D025101
D08454
DB00165
EINECS 200-386-2
EINECS 200-603-0
EINECS 232-503-8
Godabion
Gravidox
HMS1569N08
HMS2093L07
HSDB 1212
Hexa-Betalin
Hexa-Betalin (R)
Hexa-betalin (TN)
Hexabetalin
Hexabione hydrochloride
 
Hexavibex
Hexermin
Hexermine
Hexobion
Hydoxin
I02-1897
I02-2297
KST-1A8556
LS-134393
LS-187072
LS-2332
MLS001074329
MLS002153915
MolPort-002-137-856
MolPort-002-319-991
MolPort-005-933-330
NCGC00016261-01
NCGC00164317-01
NCGC00180946-01
NSC 36225
NSC36225
NSC36225 (HCL)
Nestrex
Oprea1_061614
P0561
P4722_SIAL
P5669_SIGMA
P6280_SIGMA
P8666_SIGMA
P9755_SIAL
PN
PN HCl
PYRIDOXINE HYDROCHLORIDE
PYRIDOXINE HYDROCHLORIDE, U.S.P.
Paxadon
Piridossina
Piridossina [DCIT]
Piridoxina
Piridoxina [INN-Spanish]
Prestwick0_000623
Prestwick1_000623
Prestwick2_000623
Prestwick3_000623
Prestwick_925
Pydox
Pyridipca
Pyridox
Pyridoxin
Pyridoxin hydrochloride
Pyridoxine
Pyridoxine (INN)
Pyridoxine HCl
Pyridoxine Hydrochloride (B6)
Pyridoxine [INN:BAN]
Pyridoxine chloride
Pyridoxine hydrochloride (JP15/USP)
Pyridoxine hydrochloride [USAN:JAN]
Pyridoxine hydrogen chloride
Pyridoxine monohydrochloride
Pyridoxine, hydrochloride
Pyridoxine-HCl Microencapsulated
Pyridoxinium chloride
Pyridoxinum
Pyridoxinum [INN-Latin]
Pyridoxinum hydrochloricum
Pyridoxinum hydrochloricum (Hungarian)
Pyridoxol
Pyridoxol hydrochloride
Pyridoxol, hydrochloride
Pyridoxolum
Rodex
Rodex (R)
Rodex TD
SMP2_000230
SMR000674613
SPBio_002805
STK177324
STOCK1N-08684
Spondylonal
Tex Six T.R.
TimTec1_000657
UNII-68Y4CF58BV
UNII-KV2JZ1BI6Z
Vitamin B 6
Vitamin B6
Vitamin B6-hydrochloride
Vitamin V6
Vitamin V6 (TN)
Vitamin-?B6
Vitamin-?B6 hydrochloride
Vitaped
WLN: T6NJ B1 CQ D1Q E1Q &GH
ZINC00049154
ZINC21983293
bmse000288
c1302
component of Alestrol
nchembio.93-comp1
pyridoxine
vitamin B6
2
Pyridoxalapproved, nutraceutical18566-72-81050
Synonyms:
2-methyl-3-hydroxy-4-formyl-5-hydroxymethylpyridine
3-Hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxaldehyde
3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridinecarboxaldehyde
 
3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde
3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxaldehyde
Piridoxal
Pyridoxal
Pyridoxaldehyde
3Vitamin B 6186
4
OrnithineNutraceutical693184-13-26262, 389
Synonyms:
(+)-S-Ornithine
(+/-)-2,5-Diaminopentanoic acid monohydrochloride
(S)-2,5-Diaminopentanoate
(S)-2,5-Diaminopentanoic acid
(S)-Ornithine
(S)-a,D-Diaminovalerate
(S)-a,D-Diaminovaleric acid
2,5-Diaminopentanoic acid hydrochloride
5-Amino-L-Norvaline
D -2,5-Diaminopentanoic acid
D-Ornithine
DL -2,5-Diaminopentanoic acid
DL-ornithine
DL-ornithine HCL
DL-ornithine monohydrochloride
DL-ornithine, hydrochloride
 
L -2,5-Diaminopentanoic acid
L-(-)-Ornithine
L-Ornithine
L-Ornithine hydrochloride
L-Ornithine hydrochloride (van)
L-Ornithine monohydrochloride
L-Ornithine, monohydrochloride
L-Ornithine-carboxy-14C hydrochloride
MonohydrochlorideDL-Ornithine
Monohydrochloridel-Ornithine
Ornithine DL-form HCL
Ornithine DL-form monohydrochloride
Ornithine hydrochloride
Ornithine hydrochloride (van)
Ornithine monohydrochloride
Ornithine, hydrochloride (1:1)
Ornithine, monohydrochloride
Poly-L-ornithine hydrochloride
5
Pyridoxal Phosphatenutraceutical1454-47-71051
Synonyms:
(4-Formyl-5-hydroxy-6-methyl(3-pyridyl))methyl dihydrogen phosphate
(4-formyl-5-hydroxy-6-methyl-3-pyridinyl)methyl dihydrogen phosphate
(4-formyl-5-hydroxy-6-methylpyridin-3-yl)methyl dihydrogen phosphate
2-Methyl-3-hydroxy-4-formyl-5-hydroxymethylpyridine-5-calcium phosphate
2-Methyl-3-hydroxy-4-formyl-5-hydroxymethylpyridine-5-calcium phosphate trihydrate
2-Methyl-3-hydroxy-4-formyl-5-pyridylmethylphosphoric acid
3-Hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde
3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate
3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde
3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]-4-pyridinecarboxaldehyde
3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate
4-Formyl-5-hydroxy-6-methyl-pyridin-3-yl)methoxyphosphonic acid
4-Pyridinecarboxaldehyde, 3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]- (9CI)
52064-48-9
52441-27-7
54-47-7
A26BDB6A-282A-4D13-A916-7B2B215B0FD6
AC1L1AM8
AC1Q2P2R
Apolon B(sub 6)
Apolon B6
Biosechs
C00018
CHEBI:18405
CHEMBL82202
CID1051
Codecarboxylase
Coenzyme B6
DB00114
EINECS 200-208-3
HI-Pyridoxin
Hairoxal
Hexermin P
Hexermin-P
Hi-Pyridoxin
Hiadelon
Himitan
Isonicotinaldehyde, 3-hydroxy-5-(hydroxymethyl)-2-methyl-, 5-(dihydrogen phosphate)
LS-134383
MolPort-003-939-335
NCGC00166300-01
NSC 82388
NSC82388
P-5'-P
PAL-P
PLP
PYRIDOXAL-5-PHOSPHATE
Pal-P
Phosphopyridoxal
Phosphopyridoxal coenzyme
Phosphoric acid mono-(4-formyl-5-hydroxy-6-methyl-pyridin-3-ylmethyl) ester
 
Phosphoridoxal coenzyme
Pidopidon
Piodel
Pydoxal
Pyrido
Pyridoxal 5'-(dihydrogen phosphate)
Pyridoxal 5'-phosphate
Pyridoxal 5'-phosphate hydrate
Pyridoxal 5'-phosphate monohydrate - Vitamin B6
Pyridoxal 5'-phosphate monohydrate, vitamin B6
Pyridoxal 5-monophosphoric acid ester
Pyridoxal 5-phosphate
Pyridoxal P
Pyridoxal monophosphate
Pyridoxal phosphate
Pyridoxal phosphate (6CI)
Pyridoxal phosphate [JAN]
Pyridoxal phosphate anhydrous
Pyridoxal phosphate treated .beta.-lactoglobulin from bovine whey
Pyridoxal, 5-(dihydrogen phosphate)
Pyridoxal, 5-(dihydrogen phosphate) (8CI)
Pyridoxal, 5-(dihydrogenphosphate)
Pyridoxal-5'-phosphate
Pyridoxal-5-Phosphate Hydrate
Pyridoxal-5-monophosphate
Pyridoxal-5P
Pyridoxal-P
Pyridoxaldehyde phosphate
Pyridoxyl phosphate
Pyromijin
SBB065295
SGCUT00188
SRI 2392
Sechvitan
Sechvitan, Vitahexin P
TL8005582
VITAMIN B6 COMPLEX
Vitahexin P
Vitahexin-P
Vitamin B6 phosphate
Vitamin B6 phosphate (ester)
Vitazechs
bmse000111
nchembio.237-comp3
nchembio.266-comp20
nchembio861-comp1
pyridoxal 5-monophosphoric acid ester
pyridoxal 5'-phosphate
pyridoxal 5-phosphate
pyridoxal phosphate
pyridoxal-5P
pyridoxal-P
to_000077
6arginineNutraceutical408

Interventional clinical trials:

idNameStatusNCT IDPhase
1Molecular Genetics of Retinal DegenerationsCompletedNCT00231010
2Gyrate Atrophy of the Choroid and RetinaCompletedNCT00001166

Search NIH Clinical Center for Bietti Crystalline Corneoretinal Dystrophy

Genetic Tests for Bietti Crystalline Corneoretinal Dystrophy

About this section

Genetic tests related to Bietti Crystalline Corneoretinal Dystrophy:

id Genetic test Affiliating Genes
1 Bietti Crystalline Corneoretinal Dystrophy26
2 Bietti Crystalline Dystrophy24 CYP4V2

Anatomical Context for Bietti Crystalline Corneoretinal Dystrophy

About this section

MalaCards organs/tissues related to Bietti Crystalline Corneoretinal Dystrophy:

35
Retina, Eye, Skin

Animal Models for Bietti Crystalline Corneoretinal Dystrophy or affiliated genes

About this section

Publications for Bietti Crystalline Corneoretinal Dystrophy

About this section

Articles related to Bietti Crystalline Corneoretinal Dystrophy:

(show all 11)
idTitleAuthorsYear
1
Identification and population history of CYP4V2 mutations in patients with Bietti crystalline corneoretinal dystrophy. (28051075)
2017
2
Identification of CYP4V2 mutation in 36 Chinese families with Bietti crystalline corneoretinal dystrophy. (26971461)
2016
3
Novel CYP4V2 mutations associated with Bietti crystalline corneoretinal dystrophy in Chinese patients. (26085992)
2015
4
Identification of CYP4V2 mutation in 21 families and overview of mutation spectrum in Bietti crystalline corneoretinal dystrophy. (21565171)
2011
5
In vivo confocal microscopic findings of 2 patients with Bietti crystalline corneoretinal dystrophy. (20299976)
2010
6
Crystal deposits on the lens capsules in Bietti crystalline corneoretinal dystrophy associated with a mutation in the CYP4V2 gene. (19508456)
2010
7
Bietti crystalline corneoretinal dystrophy associated with CYP4V2 gene mutations. (17249554)
2006
8
Recessive mutations in the CYP4V2 gene in East Asian and Middle Eastern patients with Bietti crystalline corneoretinal dystrophy. (15937078)
2005
9
Novel mutations in the CYP4V2 gene associated with Bietti crystalline corneoretinal dystrophy. (16179904)
2005
10
Bietti crystalline corneoretinal dystrophy is caused by mutations in the novel gene CYP4V2. (15042513)
2004
11
Genetic linkage of Bietti crystallin corneoretinal dystrophy to chromosome 4q35. (11001583)
2000

Variations for Bietti Crystalline Corneoretinal Dystrophy

About this section

UniProtKB/Swiss-Prot genetic disease variations for Bietti Crystalline Corneoretinal Dystrophy:

69
id Symbol AA change Variation ID SNP ID
1CYP4V2p.Trp44ArgVAR_023084rs119103282
2CYP4V2p.Gly61SerVAR_023085rs119103285
3CYP4V2p.Glu79AspVAR_023086rs199476185
4CYP4V2p.Ile111ThrVAR_023087rs119103283
5CYP4V2p.Met123ValVAR_023088rs149684063
6CYP4V2p.His331ProVAR_023089rs199476197
7CYP4V2p.Ser341ProVAR_023090rs199476199
8CYP4V2p.Arg508HisVAR_023091rs119103284

Clinvar genetic disease variations for Bietti Crystalline Corneoretinal Dystrophy:

5 (show all 33)
id Gene Variation Type Significance SNP ID Assembly Location
1CYP4V2NM_207352.3(CYP4V2): c.1393A> G (p.Arg465Gly)SNVPathogenicrs144109267GRCh37Chr 4, 187130414: 187130414
2CYP4V2NM_207352.3(CYP4V2): c.1396A> G (p.Asn466Asp)SNVPathogenicrs797045181GRCh37Chr 4, 187130417: 187130417
3CYP4V2NM_207352.3(CYP4V2): c.130T> A (p.Trp44Arg)SNVPathogenicrs119103282GRCh37Chr 4, 187113107: 187113107
4CYP4V2NM_207352.3(CYP4V2): c.332T> C (p.Ile111Thr)SNVPathogenicrs119103283GRCh37Chr 4, 187117161: 187117161
5CYP4V2NM_207352.3(CYP4V2): c.1523G> A (p.Arg508His)SNVPathogenicrs119103284GRCh37Chr 4, 187131740: 187131740
6CYP4V2NM_207352.3(CYP4V2): c.181G> A (p.Gly61Ser)SNVPathogenicrs119103285GRCh37Chr 4, 187113158: 187113158
7CYP4V2NM_207352.3(CYP4V2): c.1091-2A> GSNVPathogenicrs199476183GRCh37Chr 4, 187130017: 187130017
8CYP4V2NM_207352.3(CYP4V2): c.1020G> A (p.Trp340Ter)SNVPathogenicrs199476198GRCh37Chr 4, 187126386: 187126386
9CYP4V2NM_207352.3(CYP4V2): c.1021T> C (p.Ser341Pro)SNVPathogenicrs199476199GRCh37Chr 4, 187126387: 187126387
10CYP4V2NM_207352.3(CYP4V2): c.1157A> C (p.Lys386Thr)SNVPathogenicrs199476200GRCh37Chr 4, 187130085: 187130085
11CYP4V2NM_207352.3(CYP4V2): c.1169G> A (p.Arg390His)SNVPathogenicrs199476201GRCh37Chr 4, 187130097: 187130097
12CYP4V2NM_207352.3(CYP4V2): c.1187C> T (p.Pro396Leu)SNVPathogenicrs199476202GRCh37Chr 4, 187130115: 187130115
13CYP4V2NM_207352.3(CYP4V2): c.1198C> T (p.Arg400Cys)SNVPathogenicrs138444697GRCh37Chr 4, 187130126: 187130126
14CYP4V2NM_207352.3(CYP4V2): c.1199G> A (p.Arg400His)SNVPathogenicrs199476203GRCh37Chr 4, 187130127: 187130127
15CYP4V2NM_207352.3(CYP4V2): c.1226-6_1235delTGACAGCAGGTTACAGdeletionPathogenicrs199476184GRCh37Chr 4, 187130241: 187130256
16CYP4V2NM_207352.3(CYP4V2): c.1348C> T (p.Gln450Ter)SNVPathogenicrs199476204GRCh37Chr 4, 187130369: 187130369
17CYP4V2NM_207352.3(CYP4V2): c.1445C> A (p.Ser482Ter)SNVPathogenicrs146494374GRCh37Chr 4, 187131662: 187131662
18CYP4V2NM_207352.3(CYP4V2): c.1526C> T (p.Pro509Leu)SNVPathogenicrs199476205GRCh37Chr 4, 187131743: 187131743
19CYP4V2NM_207352.3(CYP4V2): c.237G> T (p.Glu79Asp)SNVPathogenicrs199476185GRCh37Chr 4, 187115676: 187115676
20CYP4V2NM_207352.3(CYP4V2): c.253C> T (p.Arg85Cys)SNVPathogenicrs199476186GRCh37Chr 4, 187115692: 187115692
21CYP4V2NM_207352.3(CYP4V2): c.283G> A (p.Gly95Arg)SNVPathogenicrs199476187GRCh37Chr 4, 187115722: 187115722
22CYP4V2NM_207352.3(CYP4V2): c.327+1G> ASNVPathogenicrs199476182GRCh37Chr 4, 187115767: 187115767
23CYP4V2NM_207352.3(CYP4V2): c.335T> G (p.Leu112Ter)SNVPathogenicrs199476188GRCh37Chr 4, 187117164: 187117164
24CYP4V2NM_207352.3(CYP4V2): c.400G> T (p.Gly134Ter)SNVPathogenicrs199476189GRCh37Chr 4, 187117229: 187117229
25CYP4V2NM_207352.3(CYP4V2): c.518T> G (p.Leu173Trp)SNVPathogenicrs199476190GRCh37Chr 4, 187118198: 187118198
26CYP4V2NM_207352.3(CYP4V2): c.655T> C (p.Tyr219His)SNVPathogenicrs199476191GRCh37Chr 4, 187118737: 187118737
27CYP4V2NM_207352.3(CYP4V2): c.759dupA (p.His254Thrfs)duplicationPathogenicrs199476192GRCh37Chr 4, 187120195: 187120195
28CYP4V2NM_207352.3(CYP4V2): c.761A> G (p.His254Arg)SNVPathogenicrs199476193GRCh37Chr 4, 187120197: 187120197
29CYP4V2NM_207352.3(CYP4V2): c.802-8_810del17insGCindelPathogenicrs207482233GRCh37Chr 4, 187122303: 187122319
30CYP4V2NM_207352.3(CYP4V2): c.958C> T (p.Arg320Ter)SNVPathogenicrs199476194GRCh37Chr 4, 187122467: 187122467
31CYP4V2NM_207352.3(CYP4V2): c.971A> T (p.Asp324Val)SNVPathogenicrs199476195GRCh37Chr 4, 187122480: 187122480
32CYP4V2NM_207352.3(CYP4V2): c.974C> T (p.Thr325Ile)SNVPathogenicrs199476196GRCh37Chr 4, 187122483: 187122483
33CYP4V2NM_207352.3(CYP4V2): c.992A> C (p.His331Pro)SNVPathogenicrs199476197GRCh37Chr 4, 187126358: 187126358

Expression for genes affiliated with Bietti Crystalline Corneoretinal Dystrophy

About this section
Search GEO for disease gene expression data for Bietti Crystalline Corneoretinal Dystrophy.

Pathways for genes affiliated with Bietti Crystalline Corneoretinal Dystrophy

About this section

GO Terms for genes affiliated with Bietti Crystalline Corneoretinal Dystrophy

About this section

Sources for Bietti Crystalline Corneoretinal Dystrophy

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet